Karyopharm Therapeut
(KPTI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -124,088 | -162,808 | -110,996 | -57,414 | -196,273 |
| Depreciation Amortization | 3,129 | 2,653 | 1,998 | 1,090 | 10,462 |
| Accounts receivable | -9,616 | -5,871 | -5,006 | -4,962 | -5,019 |
| Accounts payable and accrued liabilities | -2,847 | -3,569 | -2,141 | -1,410 | 3,465 |
| Other Working Capital | -23,189 | -2,166 | -14,753 | -3,991 | 1,170 |
| Other Operating Activity | 49,495 | 39,170 | 22,262 | 13,799 | 25,961 |
| Operating Cash Flow | $-107,116 | $-132,591 | $-108,636 | $-52,888 | $-160,234 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -212 | -5 | N/A | N/A | -145 |
| Purchase Of Investment | -45,228 | -45,228 | -34,732 | -25,764 | -274,577 |
| Sale Of Investment | 192,780 | 162,303 | 124,376 | 68,950 | 221,037 |
| Other Investing Activity | -5,500 | -6,000 | 0 | 0 | 0 |
| Investing Cash Flow | $141,840 | $111,070 | $89,644 | $43,186 | $-53,685 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 13,648 | 12,752 | 12,736 | 10,676 | 172,083 |
| Other Financing Activity | 60,000 | 60,000 | 60,000 | 0 | 0 |
| Financing Cash Flow | $73,648 | $72,752 | $72,736 | $10,676 | $172,083 |
| Exchange Rate Effect | -48 | 87 | -155 | -91 | 268 |
| Beginning Cash Position | 89,121 | 89,121 | 89,121 | 89,121 | 130,689 |
| End Cash Position | 197,445 | 140,439 | 142,710 | 90,004 | 89,121 |
| Net Cash Flow | $108,324 | $51,318 | $53,589 | $883 | $-41,568 |
| Free Cash Flow | |||||
| Operating Cash Flow | -107,116 | -132,591 | -108,636 | -52,888 | -160,234 |
| Capital Expenditure | -212 | -5 | N/A | N/A | -145 |
| Free Cash Flow | -107,328 | -132,596 | -108,636 | -52,888 | -160,379 |